Unknown

Dataset Information

0

Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.


ABSTRACT: By analyzing and simulating inactive conformations of the highly homologous dopamine D2 and D3 receptors (D2R and D3R), we find that eticlopride binds D2R in a pose very similar to that in the D3R/eticlopride structure but incompatible with the D2R/risperidone structure. In addition, risperidone occupies a sub-pocket near the Na+ binding site, whereas eticlopride does not. Based on these findings and our experimental results, we propose that the divergent receptor conformations stabilized by Na+-sensitive eticlopride and Na+-insensitive risperidone correspond to different degrees of inverse agonism. Moreover, our simulations reveal that the extracellular loops are highly dynamic, with spontaneous transitions of extracellular loop 2 from the helical conformation in the D2R/risperidone structure to an extended conformation similar to that in the D3R/eticlopride structure. Our results reveal previously unappreciated diversity and dynamics in the inactive conformations of D2R. These findings are critical for rational drug discovery, as limiting a virtual screen to a single conformation will miss relevant ligands.

SUBMITTER: Lane JR 

PROVIDER: S-EPMC7053997 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.

Lane J Robert JR   Abramyan Ara M AM   Adhikari Pramisha P   Keen Alastair C AC   Lee Kuo-Hao KH   Sanchez Julie J   Verma Ravi Kumar RK   Lim Herman D HD   Yano Hideaki H   Javitch Jonathan A JA   Shi Lei L  

eLife 20200127


By analyzing and simulating inactive conformations of the highly homologous dopamine D<sub>2</sub> and D<sub>3</sub> receptors (D<sub>2</sub>R and D<sub>3</sub>R), we find that eticlopride binds D<sub>2</sub>R in a pose very similar to that in the D<sub>3</sub>R/eticlopride structure but incompatible with the D<sub>2</sub>R/risperidone structure. In addition, risperidone occupies a sub-pocket near the Na<sup>+</sup> binding site, whereas eticlopride does not. Based on these findings and our expe  ...[more]

Similar Datasets

| S-EPMC5234269 | biostudies-literature
| S-EPMC6758242 | biostudies-literature
| S-EPMC4314200 | biostudies-literature
| S-EPMC3530844 | biostudies-literature
| S-EPMC6616020 | biostudies-literature
| S-EPMC4821629 | biostudies-literature
| S-EPMC2981362 | biostudies-literature
| S-EPMC4440838 | biostudies-literature
| S-EPMC3435408 | biostudies-literature
| S-EPMC2607046 | biostudies-literature